Patients with psoriasis often have lower success treatments with biologic agents in clinical practice than clinical trials, leading to higher doses and therefore higher annual treatment costs.
Alison Rodriguez
Advertisement
Articles by Alison Rodriguez
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Sudden Death in HFpEF Often Preceded by Clinical Decline
2
FDA Issues Complete Response Letter for Cingulate's Once-Daily ADHD Drug CTx-1301
3
How Often Do Health Insurers Deny Doctor-Recommended Care?
4
New Data Support Pimicotinib as Durable for Rare Tenosynovial Giant Cell Tumor
5